Medical Safety Alert: Crestor 5mg Tablets

Potentially a rogue blister and carton may be present in a batch of Crestor 5mg Tablets – Class 4 Caution in Use (EL (16)A/03).

One pack of Crestor 5mg tablets parallel imported by BR Lewis Pharmaceuticals Ltd (originator name Provisacor) has been found to contain a rogue blister of 20mg tablets (batch S348A). The rogue blister was over-labelled as 5mg tablets, batch S347A/3153. The second blister in the pack was correct (5mg).

Pharmacists are asked to check any remaining stock of Crestor 5mg tablets batch S347A/3153 to ensure that the carton and both blisters are correct.

If a 20mg carton or blister is found, pharmacists should contact AAH Pharmaceuticals Regulatory Department, email: gb-AAHregulatory@AAH.co.uk; tel 02476 532359 to arrange uplift and credit.

For more details, see the MHRA's Medical Safety Alert.

Latest discussions

  1. Are pharmacists guinea pigs for covid19

    Looks like we are! Surgeries and dentist...

  2. Are pharmacists guinea pigs for covid19

    I agree we work behind screens, but that...

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.